{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:52:31Z","timestamp":1792684351724,"version":"4.5.0"},"reference-count":104,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>To overcome the obstacle of antimicrobial resistance, researchers are investigating the use of phage therapy as an alternative and\/or supplementation to antibiotics to treat and prevent infections both in humans and in animals. In the first part of this review, we describe the unique biological characteristics of bacteriophages and the crucial aspects influencing the success of phage therapy. However, despite their efficacy and safety, there is still no specific legislation that regulates their use. In the second part of this review, we describe the comprehensive research done in the past and recent years to address the use of phage therapy for the treatment and prevention of bacterial disease affecting domestic animals as an alternative to antibiotic treatments. While in farm animals, phage therapy efficacy perspectives have been widely studied in vitro and in vivo, especially for zoonoses and diseases linked to economic losses (such as mastitis), in pets, studies are still few and rather recent.<\/jats:p>","DOI":"10.3390\/antibiotics10040421","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T03:04:06Z","timestamp":1618196646000},"page":"421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Phage Therapy in Veterinary Medicine"],"prefix":"10.3390","volume":"10","author":[{"given":"Rosa","family":"Loponte","sequence":"first","affiliation":[{"name":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, via Federico Delpino, 1, 80137 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Pagnini","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, via Federico Delpino, 1, 80137 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Iovane","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, via Federico Delpino, 1, 80137 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-6882","authenticated-orcid":false,"given":"Giuseppe","family":"Pisanelli","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, via Federico Delpino, 1, 80137 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bies.201400152","article-title":"A century of phage research: Bacteriophages and the shaping of modern biology","volume":"37","author":"Keen","year":"2015","journal-title":"Bioessays"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jam.14535","article-title":"Therapeutic bacteriophages as a rescue treatment for drug-resistant infections\u2014An in vivo studies overview","volume":"128","author":"Kwiatek","year":"2020","journal-title":"J. Appl. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12985-019-1260-3","article-title":"Veterinary use of bacteriophage therapy in intensively-reared livestock","volume":"16","author":"Gigante","year":"2019","journal-title":"Virol. J."},{"key":"ref_5","first-page":"267","article-title":"Phage therapy: Past history and future prospects","volume":"47","author":"Carlton","year":"1999","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.mib.2008.09.004","article-title":"Bacteriophage genomics","volume":"11","author":"Hatfull","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.mib.2003.09.004","article-title":"Bacteriophage genomics","volume":"6","author":"Hendrix","year":"2003","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrmicro1750","article-title":"Marine viruses--major players in the global ecosystem","volume":"5","author":"Suttle","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00705-020-04577-8","article-title":"Taxonomy of prokaryotic viruses: 2018-2019 update from the ICTV Bacterial and Archaeal Viruses Subcommittee","volume":"165","author":"Adriaenssens","year":"2020","journal-title":"Arch. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/ismej.2015.47","article-title":"The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin","volume":"9","author":"Liu","year":"2015","journal-title":"ISME J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/jvi.40.2.551-559.1981","article-title":"Isolation and characterization of a new bacteriophage, Cp-1, infecting Streptococcus pneumoniae","volume":"40","author":"Ronda","year":"1981","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e36135","DOI":"10.5812\/jjm.36135","article-title":"Isolation, Characterization, and Antibacterial Activity of Bacteriophages Against Methicillin-Resistant Staphylococcus aureus in Pakistan","volume":"9","author":"Rasool","year":"2016","journal-title":"Jundishapur. J. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/AEM.00428-08","article-title":"Isolation and characterization of bacteriophages infecting the fish pathogen Flavobacterium psychrophilum","volume":"74","author":"Stenholm","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/1574-6968.12277","article-title":"Isolation and characterization of five lytic bacteriophages infecting a Vibrio strain closely related to Vibrio owensii","volume":"348","author":"Yu","year":"2013","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jakhetia, R., Talukder, K.A., and Verma, N.K. (2013). Isolation, characterization and comparative genomics of bacteriophage SfIV: A novel serotype converting phage from Shigella flexneri. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-677"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AEM.64.2.575-580.1998","article-title":"Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa","volume":"64","author":"Jensen","year":"1998","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11259-018-9736-y","article-title":"Isolation and characterization of two lytic bacteriophages against Staphylococcus aureus from India: Newer therapeutic agents against Bovine mastitis","volume":"42","author":"Ganaie","year":"2018","journal-title":"Vet. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/aem.57.3.721-726.1991","article-title":"Use of ultrafiltration to isolate viruses from seawater which are pathogens of marine phytoplankton","volume":"57","author":"Suttle","year":"1991","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-60327-164-6_4","article-title":"Isolation of cyanophages from aquatic environments","volume":"501","author":"Millard","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1128\/AEM.70.12.7365-7371.2004","article-title":"Milk contamination and resistance to processing conditions determine the fate of Lactococcus lactis bacteriophages in dairies","volume":"70","author":"Madera","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_22","first-page":"51","article-title":"The factors affecting effectiveness of treatment in phages therapy","volume":"5","year":"2014","journal-title":"Front. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AEM.01711-08","article-title":"Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods","volume":"75","author":"Guenther","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2672.2006.02918.x","article-title":"Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K","volume":"101","author":"Gill","year":"2006","journal-title":"J. Appl. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/fpd.2009.0432","article-title":"Reduction of Listeria monocytogenes on the surface of fresh channel catfish fillets by bacteriophage Listex P100","volume":"7","author":"Soni","year":"2010","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.micpath.2016.08.001","article-title":"In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB\/c mice","volume":"99","author":"Chadha","year":"2016","journal-title":"Microb. Pathog."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fischetti, V.A. (2018). Development of Phage Lysins as Novel Therapeutics: A Historical Perspective. Viruses, 10.","DOI":"10.3390\/v10060310"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Shen, Y., Barros, M., Vennemann, T., Gallagher, D.T., Yin, Y., Linden, S.B., Heselpoth, R.D., Spencer, D.J., Donovan, D.M., and Moult, J. (2016). A bacteriophage endolysin that eliminates intracellular streptococci. Elife, 5.","DOI":"10.7554\/eLife.13152"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fmicb.2016.00208","article-title":"Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity","volume":"7","author":"Oliveira","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e1062590","DOI":"10.1080\/21597081.2015.1062590","article-title":"Antimicrobial bacteriophage-derived proteins and therapeutic applications","volume":"5","author":"Roach","year":"2015","journal-title":"Bacteriophage"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1586\/eri.11.90","article-title":"Bacteriophage therapy: Potential uses in the control of antibiotic-resistant pathogens","volume":"9","author":"Burrowes","year":"2011","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1752-4571.2011.00236.x","article-title":"Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms","volume":"5","author":"Zhang","year":"2012","journal-title":"Evol. Appl."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cairns, J., Becks, L., Jalasvuori, M., and Hiltunen, T. (2017). Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution. Philos. Trans. R. Soc. Lond. B Biol. Sci., 372.","DOI":"10.1098\/rstb.2016.0040"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resmic.2012.08.008","article-title":"Phage-antibiotic synergism: A possible approach to combatting Pseudomonas aeruginosa","volume":"164","author":"Knezevic","year":"2013","journal-title":"Res. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1263\/jbb.100.280","article-title":"Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice","volume":"100","author":"Tanji","year":"2005","journal-title":"J. Biosci. Bioeng."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1128\/AEM.00246-08","article-title":"Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery","volume":"74","author":"Ma","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/AEM.69.8.5032-5036.2003","article-title":"Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages","volume":"69","author":"Goode","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2672.2010.04863.x","article-title":"In vitro lung delivery of bacteriophages KS4-M and PhiKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis","volume":"110","author":"Golshahi","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/jmm.0.029744-0","article-title":"Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection","volume":"60","author":"Khawaldeh","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"Sulakvelidze","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/jb.12.4.245-261.1926","article-title":"The Bacteriophage in Relation to Salmonella Pullora Infection in the Domestic Fowl","volume":"12","author":"Pyle","year":"1926","journal-title":"J. Bacteriol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"European Food Safety Authority, and European Centre for Disease Prevention and Control (2018). The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2017. EFSA J., 16, e05500.","DOI":"10.2903\/j.efsa.2018.5500"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1745-4565.2001.tb00305.x","article-title":"Attempts to utilize bacteriophage to combat Salmonella Enterica Serovar Entemtidis infection in chickens","volume":"21","author":"Sklar","year":"2001","journal-title":"J. Food Saf."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/01445340500112157","article-title":"Oral treatment with bacteriophages reduces the concentration of Salmonella Enteritidis PT4 in caecal contents of broilers","volume":"34","author":"Fiorentin","year":"2005","journal-title":"Avian Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1128\/AEM.00049-07","article-title":"Bacteriophage therapy to reduce Salmonella colonization of broiler chickens","volume":"73","author":"Atterbury","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1637\/8091-082007-Reg","article-title":"Bacteriophage treatment reduces Salmonella colonization of infected chickens","volume":"52","author":"Borie","year":"2008","journal-title":"Avian Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fmicb.2016.01253","article-title":"Prophylactic Bacteriophage Administration More Effective than Post-infection Administration in Reducing Salmonella enterica serovar Enteritidis Shedding in Quail","volume":"7","author":"Ahmadi","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_51","unstructured":"Pattison, M. (2008). Poultry Diseases, Elsevier\/Butterworth-Heinemann. [6th ed.]."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ps\/81.4.437","article-title":"Prevention of Escherichia coli respiratory infection in broiler chickens with bacteriophage (SPR02)","volume":"81","author":"Huff","year":"2002","journal-title":"Poult. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/ps\/82.7.1108","article-title":"Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection","volume":"82","author":"Huff","year":"2003","journal-title":"Poult. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/ps\/83.12.1944","article-title":"Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers","volume":"83","author":"Huff","year":"2004","journal-title":"Poult. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.vetmic.2010.05.015","article-title":"In vivo efficiency evaluation of a phage cocktail in controlling severe colibacillosis in confined conditions and experimental poultry houses","volume":"146","author":"Oliveira","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3382\/ps.2014-04282","article-title":"Environmental augmentation with bacteriophage prevents colibacillosis in broiler chickens","volume":"93","author":"Huff","year":"2014","journal-title":"Poult. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CDLI.5.3.294-298.1998","article-title":"Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves","volume":"5","author":"Barrow","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.vetmic.2005.06.002","article-title":"Phage therapy reduces Campylobacter jejuni colonization in broilers","volume":"109","author":"Wagenaar","year":"2005","journal-title":"Vet. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AEM.71.8.4885-4887.2005","article-title":"Correlation of Campylobacter bacteriophage with reduced presence of hosts in broiler chicken ceca","volume":"71","author":"Atterbury","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/AEM.71.8.4885-4887.2005","article-title":"Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens","volume":"71","author":"Atterbury","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Jackel, C., Hammerl, J.A., and Hertwig, S. (2019). Campylobacter Phage Isolation and Characterization: What We Have Learned So Far. Methods Protoc., 2.","DOI":"10.3390\/mps2010018"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1128\/AEM.00184-06","article-title":"Phase-variable surface structures are required for infection of Campylobacter jejuni by bacteriophages","volume":"72","author":"Coward","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1128\/JB.05276-11","article-title":"Bacteriophage F336 recognizes the capsular phosphoramidate modification of Campylobacter jejuni NCTC11168","volume":"193","author":"Sorensen","year":"2011","journal-title":"J. Bacteriol."},{"key":"ref_64","first-page":"11","article-title":"Phase variable expression of capsular polysaccharide modifications allows Campylobacter jejuni to avoid bacteriophage infection in chickens","volume":"2","author":"Fodor","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Hammerl, J.A., Jackel, C., Alter, T., Janzcyk, P., Stingl, K., Knuver, M.T., and Hertwig, S. (2014). Reduction of Campylobacter jejuni in broiler chicken by successive application of group II and group III phages. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114785"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Carvalho, C.M., Gannon, B.W., Halfhide, D.E., Santos, S.B., Hayes, C.M., Roe, J.M., and Azeredo, J. (2010). The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC Microbiol., 10.","DOI":"10.1186\/1471-2180-10-232"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fmicb.2019.00476","article-title":"Phage Biocontrol of Campylobacter jejuni in Chickens Does Not Produce Collateral Effects on the Gut Microbiota","volume":"10","author":"Richards","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1637\/8953-060509-Reg.1","article-title":"Bacteriophage therapy for control of necrotic enteritis of broiler chickens experimentally infected with Clostridium perfringens","volume":"54","author":"Miller","year":"2010","journal-title":"Avian Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4102\/jsava.v77i2.344","article-title":"A review of the factors affecting the costs of bovine mastitis","volume":"77","author":"Petrovski","year":"2006","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/AEM.71.4.1836-1842.2005","article-title":"Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals","volume":"71","author":"Ross","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1472-765X.2005.01781.x","article-title":"Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections","volume":"41","author":"Ross","year":"2005","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1128\/AAC.01630-05","article-title":"Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle","volume":"50","author":"Gill","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.3168\/jds.2008-1744","article-title":"Prevalence of bacteriophages infecting Staphylococcus aureus in dairy samples and their potential as biocontrol agents","volume":"92","author":"Garcia","year":"2009","journal-title":"J. Dairy Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00705-011-1160-3","article-title":"Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains","volume":"157","author":"Kwiatek","year":"2012","journal-title":"Arch. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.2527\/jas.2012-5884","article-title":"Use of phages against antibiotic-resistant Staphylococcus aureus isolated from bovine mastitis","volume":"91","author":"Dias","year":"2013","journal-title":"J. Anim. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1007\/s11033-014-3457-2","article-title":"Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle","volume":"41","author":"Li","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Titze, I., Lehnherr, T., Lehnherr, H., and Kromker, V. (2020). Efficacy of Bacteriophages Against Staphylococcus aureus Isolates from Bovine Mastitis. Pharmaceuticals, 13.","DOI":"10.3390\/ph13030035"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1007\/s00253-015-6579-0","article-title":"Synergistic streptococcal phage lambdaSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis","volume":"99","author":"Schmelcher","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Shan, Y., Yang, N., Teng, D., Wang, X., Mao, R., Hao, Y., Ma, X., Fan, H., and Wang, J. (2020). Recombinant of the Staphylococcal Bacteriophage Lysin CHAPk and Its Elimination against Streptococcus agalactiae Biofilms. Microorganisms, 8.","DOI":"10.3390\/microorganisms8020216"},{"key":"ref_80","first-page":"2659","article-title":"Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs","volume":"129","author":"Smith","year":"1983","journal-title":"J. Gen. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vetmic.2008.10.021","article-title":"Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs","volume":"136","author":"Jamalludeen","year":"2009","journal-title":"Vet. Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.5713\/ajas.2012.12253","article-title":"Effect of bacteriophage supplementation on the growth performance, nutrient digestibility, blood characteristics, and fecal microbial shedding in growing pigs","volume":"25","author":"Yan","year":"2012","journal-title":"Asian-Australas. J. Anim. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1292\/jvms.11-0556","article-title":"Effect of bacteriophage in enterotoxigenic Escherichia coli (ETEC) infected pigs","volume":"74","author":"Cha","year":"2012","journal-title":"J. Vet. Med. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AEM.00785-09","article-title":"Phage therapy to reduce preprocessing Salmonella infections in market-weight swine","volume":"76","author":"Wall","year":"2010","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/fpd.2011.0905","article-title":"Direct feeding of microencapsulated bacteriophages to reduce Salmonella colonization in pigs","volume":"8","author":"Saez","year":"2011","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1292\/jvms.17-0501","article-title":"Evaluation of the broad-spectrum lytic capability of bacteriophage cocktails against various Salmonella serovars and their effects on weaned pigs infected with Salmonella Typhimurium","volume":"80","author":"Seo","year":"2018","journal-title":"J. Vet. Med. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijfoodmicro.2018.02.007","article-title":"Bacteriophages reduce Yersinia enterocolitica contamination of food and kitchenware","volume":"271","author":"Jun","year":"2018","journal-title":"Int. J. Food Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13258-019-00906-7","article-title":"Specific bacteriophage of Bordetella bronchiseptica regulates B. bronchiseptica-induced microRNA expression profiles to decrease inflammation in swine nasal turbinate cells","volume":"42","author":"Park","year":"2020","journal-title":"Genes Genom."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s13258-018-0755-4","article-title":"Bordetella bronchiseptica bateriophage suppresses B. bronchiseptica-induced inflammation in swine nasal turbinate cells","volume":"40","author":"Park","year":"2018","journal-title":"Genes Genom."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13258-019-00898-4","article-title":"Pasteurella multocida specific bacteriophage suppresses P. multocida-induced inflammation: Identification of genes related to bacteriophage signaling by Pasteurella multocida-infected swine nasal turbinate cells","volume":"42","author":"Park","year":"2020","journal-title":"Genes Genom."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00299-019-02459-1","article-title":"Production of bacteriophage-encoded endolysin, LysP11, in Nicotiana benthamiana and its activity as a potent antimicrobial agent against Erysipelothrix rhusiopathiae","volume":"38","author":"Islam","year":"2019","journal-title":"Plant Cell. Rep."},{"key":"ref_92","first-page":"957","article-title":"Public health risk of antimicrobial resistance transfer from companion animals","volume":"72","author":"Pomba","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Palma, E., Tilocca, B., and Roncada, P. (2020). Antimicrobial Resistance in Veterinary Medicine: An Overview. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061914"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/00480169.2018.1491348","article-title":"Bacteriophage therapy for management of bacterial infections in veterinary practice: What was once old is new again","volume":"66","author":"Squires","year":"2018","journal-title":"N. Z. Vet. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.burns.2006.02.012","article-title":"Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients","volume":"32","author":"Marza","year":"2006","journal-title":"Burns"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vetmic.2010.05.014","article-title":"Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before\/after clinical trial","volume":"146","author":"Hawkins","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1292\/jvms.15-0310","article-title":"Bacteriophage can lyse antibiotic-resistant Pseudomonas aeruginosa isolated from canine diseases","volume":"78","author":"Furusawa","year":"2016","journal-title":"J. Vet. Med. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rvsc.2007.09.004","article-title":"Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro","volume":"85","author":"Freitag","year":"2008","journal-title":"Res. Vet. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.rvsc.2018.11.008","article-title":"Isolation and characterization of bacteriophages active against methicillin-resistant Staphylococcus pseudintermedius","volume":"122","author":"Moodley","year":"2019","journal-title":"Res. Vet. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Pirnay, J.P., Verbeken, G., Ceyssens, P.J., Huys, I., De Vos, D., Ameloot, C., and Fauconnier, A. (2018). The Magistral Phage. Viruses, 10.","DOI":"10.3390\/v10020064"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000473872","article-title":"Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with the Topical Endolysin Staphefekt SA.100: A Report of 3 Cases","volume":"9","author":"Totte","year":"2017","journal-title":"Case Rep. Dermatol."},{"key":"ref_103","first-page":"638","article-title":"FDA Approves Bacteriophage Trial","volume":"321","author":"Voelker","year":"2019","journal-title":"JAMA"},{"key":"ref_104","first-page":"e2020023","article-title":"Comparison between American and European legislation in the therapeutical and alimentary bacteriophage usage","volume":"91","author":"Naureen","year":"2020","journal-title":"Acta Biomed."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/4\/421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:26:46Z","timestamp":1760362006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/4\/421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,11]]},"references-count":104,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["antibiotics10040421"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10040421","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,11]]}}}